KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Change in Intangibles (2016 - 2024)

Edwards Lifesciences has reported Change in Intangibles over the past 11 years, most recently at $4.6 million for Q4 2024.

  • Quarterly results put Change in Intangibles at $4.6 million for Q4 2024, changed N/A from a year ago — trailing twelve months through Sep 2025 was $4.6 million (down 81.89% YoY), and the annual figure for FY2024 was $30.0 million, up 125.56%.
  • Change in Intangibles for Q4 2024 was $4.6 million at Edwards Lifesciences, down from $5.4 million in the prior quarter.
  • Over the last five years, Change in Intangibles for EW hit a ceiling of $20.0 million in Q1 2024 and a floor of $200000.0 in Q2 2023.
  • Median Change in Intangibles over the past 3 years was $5.0 million (2024), compared with a mean of $7.3 million.
  • Peak annual rise in Change in Intangibles hit 52.67% in 2024, while the deepest fall reached 52.67% in 2024.
  • Edwards Lifesciences' Change in Intangibles stood at $300000.0 in 2020, then tumbled by 33.33% to $200000.0 in 2023, then soared by 2200.0% to $4.6 million in 2024.
  • The last three reported values for Change in Intangibles were $4.6 million (Q4 2024), $5.4 million (Q3 2024), and $20.0 million (Q1 2024) per Business Quant data.